Genasense® (Oblimersen Sodium), Fludarabine, and Rituximab in Subjects With Chronic Lymphocytic Leukemia

This study has been completed.

Study NCT00078234 Information provided by Genta Incorporated

First Received: February 20, 2004 Last Updated: November 4, 2011 History of Changes

No Study Results Posted on ClinicalTrials.gov for this Study

Study Status:	This study has been completed.
Study Completion Date:	September 2010
Primary Completion Date:	September 2008 (Final data collection date for primary outcome measure)